MENU
AMLX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Amylyx Pharmaceuticals (AMLX) Ownership - Who owns Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases... Show more
Profile
Industry
N/A
Address
43 Thorndike Street
Phone
+1 617 682-0917
Employees
384
Web
https://www.amylyx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.44B
P/E Ratio
2.81
Total Cash
180.83M
Projected Growth
N/A
Total Debt
5.96M
Revenue
-249K
Risk (Beta)
0.51
Dividend Yield
N/A
Total Cash/Share
1.70
Total Debt/Equity
N/A
Revenue/Share
-0.00 USD as % of share price
Fundamentals
AMLX
Capitalization
1.44B
P/E Ratio
2.81
Risk (Beta)
0.51
Dividend Yield
N/A
Total Cash
181M
Total Cash/Share
1.70
Total Debt
5.96M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
-0.00%
Revenue
-249K
ROE
N/A
Book Value
168M
P/B Ratio
8.56
Cash Flow
N/A
Earnings
-2.49
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
8.72
Current Revenue Per Employee
1083.33
Dividends Per Share - Security
N/A
EBITDA
-196.3M
Float
N/A
Float - Current
N/A
Gross Income Margin
-94.47
Revenue To Assets
-71.23
Shares Held By Institutions
533M
Shares Outstanding - Current
107M
Total Liabilities
26.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
256.614
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AMLX showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
43 Thorndike Street
Phone
+1 617 682-0917
Employees
384
Web
https://www.amylyx.com